Avricore Health (AVCRF) Non-Current Debt (2012 - 2022)
Avricore Health (AVCRF) posted quarterly Non-Current Debt of $29468.1 for Q4 2022.
Avricore Health (AVCRF) Non-Current Debt (2012 - 2022) Analysis & Trends
Avricore Health (AVCRF) has reported Non-Current Debt for 1 consecutive years, with $29468.1 the latest figure, recorded in Q4 2022.
- In Q4 2022, Non-Current Debt changed N/A year-over-year to $29468.1; the TTM figure through Dec 2022 stood at $29468.1 (changed N/A YoY), while the FY2022 annual figure was $30766.6, changed N/A from the prior year.
- Non-Current Debt held at $29468.1 in Q4 2022 per AVCRF's latest filing.
- Across five years, Non-Current Debt topped out at $29468.1 in Q4 2022 and bottomed at $29468.1 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 42.28 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 26.56 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 3.05 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 13.71 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 299.87 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 1.49 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 2.04 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 5.86 Bn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 29,468.12 |
| Jun 30, 2014 | -672,695.60 |
| Jun 30, 2013 | 277,145.53 |
| Jun 30, 2012 | -303,728.16 |